Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Accounts Payables (2016 - 2025)

Sanara MedTech's Accounts Payables history spans 15 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 54.28% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, up 54.28%, while the annual FY2025 figure was $2.3 million, 54.28% up from the prior year.
  • Accounts Payables reached $2.3 million in Q4 2025 per SMTI's latest filing, up from $27339.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.3 million in Q4 2025 to a low of $27339.0 in Q3 2025.
  • Average Accounts Payables over 5 years is $882570.2, with a median of $741732.0 recorded in 2022.
  • Peak YoY movement for Accounts Payables: surged 6588.11% in 2023, then plummeted 95.16% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $438154.0 in 2021, then skyrocketed by 217.86% to $1.4 million in 2022, then tumbled by 94.41% to $77805.0 in 2023, then skyrocketed by 1827.59% to $1.5 million in 2024, then skyrocketed by 54.28% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Accounts Payables are $2.3 million (Q4 2025), $27339.0 (Q3 2025), and $1.5 million (Q2 2025).